New pill targets cancer cell machinery in First-Ever human trial
Disease control
Recruiting now
This is the first study in people to test a new oral drug called ATX-295, which works by blocking a specific protein that helps cancer cells divide. The main goals are to find a safe dose and see how the body processes the drug in about 90 patients with advanced solid tumors, inc…
Phase: PHASE1 • Sponsor: Accent Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC